Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Doubt it, some peeps are picking up shares here, the AS is great and the OS will get this going very quickly with news. Anyone know anything else about the Costco relationship?
Three changes in filings with different numbers and signed will bring the attention of the SEC, not something I want to gamble on.
This CEO is in big trouble, the financials don't add up so I am out, yes those are my trades at .0025.
Spot on Sir!!
Perhaps Chris will clarify a lot of this weeks information during the interview tomorrow?
Not sure what you want other than someone to hand you a million but the reduction in share count, revenue on the horizon, and a relationship with millions of viewers. Too many here trade on emotion and will miss the boat! Funny how many hang around after selling and try to trash the co. Got to love the pennies.
Great 10Q it's time to buy!!
Yet Apple and Hoye continue their relationship and expand it, if anyone knows more about the company??
I guess you live in LA and visited the office, for a dirt lot, you must need glasses?
I am sure you realize that there are far more investors than 149. Most of the shares are held in the name of the trading institutions. It would be a nightmare to register shares in the name of each flipper or holder every day.
Time for the run at .05
A lot depends on the merger but in my opinion once you add up what we know about both companies existing share structures and outstanding debt. I see the new company coming in at around .30 to .35 with most holders of SKTO receiving 1 share of the new company for 6 of their current shares. This will bring the share count inline with NASDQ bound companies. After we have the ability to review the audited #'s and actual revenues we should easily move to the .50 - .60 range. Short term as above, long term > 1 year 2.25 - 2.50, If move to NASDQ or AMEX look for 4.25 - 6.00. This is all in my opinion and is all speculation since we really have no audited fins or accurate share count. One big if that could drastically multiply the #'s would be legalization on the federal level and rapid expansion.
Please do not consider buying or selling on my speculation, it is exactly that speculation, Thanks.
We may have to only wait 2 1/2 more weeks to really see what we have. Not much time when it comes to stocks, if they follow through we could be looking at significant gains. I do live in Marin county and I can tell you my sister teaches at Berkley, that is why I have invested a large portion of my capital in this stock. But please buy or sell only on your own DD, I do not recommend pennies as a regular investment!!
Finally got filled but the shares seem to be very tight or very controlled.
Something is not right with the L2, I have had 50000 at the current ask and they will not sell them to me, this has been for the last 5". I use Etrade??
In the past two stocks I owned that were suspended the SEC notified them well in advance of taking action. Usually they will query the company as to the complaint and wait for a response. That is usually when the company informs the investors of the query. If the company produces adequate information as to the allegations then all is good. They only proceed once the company fails to correct the information, stock distribution or flawed information. That is why I was hoping for some sort of PR indicating that AEGY was not under investigation or queried by the SEC. This is just my opinion but if they just shut down the sister company without an investigation it would be a major violation. JMHO, don't buy or sell on this information. GLTA
"I would imagine that the powers to be as AEGY and SKTO are giving the folks at Iequity an earful. I would hope that we would see a PR tomorrow reassuring us that everything is ok and progressing nicely and then maybe and up date on our situation."
This should have happened as soon as the suspension was announced, now the risk becomes fairly high. I hope that this will not be an issue for AEGY but a trading suspension is not something I want to live through again.
I agree and if you know what it takes to uplist to NASDAQ you also know we will be very happy!!!!
I smell news, got an even bigger position
I've been buying at this level and expect very little down side, my own opinion. I have a lot of shares and will continue if it goes lower to purchase more. Anyone in the pharma business recognizes how much valium and Xanax is sold nationwide and the side effects associated with these products. If Dharmanol takes only 2% of the market we could see substantial PPS rise.
NEWS
SK3 Group's (OTC PINK: SKTO) Medical Greens Is Pleased to Announce That the First Bottles of Dharmanol(TM) Are Shipping and Will Be Immediately Available on www.pharmajanes.com Among Other Places
LOS ANGELES, CA--(Marketwired - Feb 14, 2014) - SK3 Group, Inc's (OTC Pink: SKTO) subsidiary Medical Greens is pleased to announce that the first bottles of Dharmanol™ Whole Plant tablets, for which Medical Greens has the exclusive license, are shipping today. Dharmanol™ is a medical cannabis-based supplement that contains all of the natural elements of the cannabis/hemp plant that are thought to promote healing, with the exception of THC, the molecule which is responsible for the psychoactive effect -- or "high" -- of marijuana.
Dharmanol™, developed by David Hoye and Dr. Charles Apel of Berkeley Bio-Organic Research Laboratories, contains under .03% THC, less than many hemp-based health products that are sold at stores such as Costco and Walgreens. But it contains 10 mg. of the non-psychoactive phyto-cannabinoids that are present in hemp/cannabis, and are thought to contribute to the myriad of mechanisms that many university-level scientific studies have shown to be responsible for the remarkable healing power of medical marijuana.
Dharmanol™ tablets will be available soon in California through AEGY's www.pharmajanes.com delivery service and select medicinal marijuana dispensaries.
Dharmanol™ is sold in a bottle of 8 tablets. The suggested retail price for a bottle is $25.00. Each tablet contains 5 mg. cannabidiol (CBD), 5 mg. of non-psychoactive mixed carboxylates of the primary cannabinoids, 5 mg. of mixed separated terpenes and terpenoids of cannabis/hemp, 25 mg. of organic cold-pressed hemp oil, and 25 mg. of vitamin C (ascorbic acid as a preservative).
Dharmanol Citrolene™ will be released shortly. This formulation combines the phyto-cannabinoid formula found in Dharmanol™ with a substantial dose of the terpene d-Limonene. D-Limonene is found in cannabis/hemp, but also present in the rinds of certain citrus fruits. D-Limonene has been shown to bind with the same receptors as benzodiazapines such as Valium and Xanax, producing a pronounced relaxing and anti-spasmodic effect, without the negative side effects that many attribute to the synthetic pharmaceuticals.
"We are pleased to be able to start delivering this important product to market through our distribution network of dispensaries and our related web-based delivery service www.pharmajanes.com," said Artemus Mayor, President of SK3 Group, Inc. "These products are industry leading and will allow us to deliver the health benefits of medical marijuana to more patients who will not have to worry about feeling 'high' after their use. These products will contribute directly to our topline revenue growth."
FDA Statement
The statements in this document have not been evaluated or approved by the FDA. The products and statements referenced in this document are not intended to diagnose, treat, cure, or prevent any disease.
About SK3
SK3 is a healthcare logistics and fulfillment consultancy focused on the delivery of alternative care and medicine. With seasoned management, breakthrough technology and best practices, SK3 brings standardization and transparency to this rapidly growing segment of the alternative care field.
Safe Harbor Statement
This press release contains forward-looking statements within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. These forward-looking statements are based on the current plans and expectations of management and are subject to a number of uncertainties and risks that could significantly affect the company's current plans and expectations, as well as future results of operations and financial condition. A more extensive listing of risks and factors that may affect the company's business prospects and cause actual results to differ materially from those described in the forward-looking statements can be found in the reports and other documents filed by the company with the Securities and Exchange Commission. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.
Medical Greens
investors@medicalgreens.com
Investor Relations
No, my decision is based upon the information provided by the company and wether or not I can base my investing on that information. What I have here is vague JV's, many convertible notes, delay in which the company stated they did not see any problems with and no expansion on the pharm side. I'm sure Bob can clarify, unfortunately he hasn't!!
You are absolutely correct, you only lose if you sell, but you also limit your losses as well. I must trust my hard earned dollars to factual and trustworthy information provided by the company. After the last press release I did the following.
1. Domain search on the creation of the website.
2. Contacted a realtor in Elko NV
3. Called the company and asked what other clients or products do they represent.
Each individual must perform their own D/D and then base their investment decision on that information. That is all I have done and I can tell you the majority of sells these past few days have been mostly retail.
JMHO
The lack of transperancy, agreements with companys that didn't even exist until after the announcement and a large amount of convertible debt that I am sure continues to this day has forced me out with a considerable loss.
It would have been nice if our CEO would have updated us as to why he missed his self imposed deadline for the China approval of 90 days, that with the miss on the acquisition target scheduled for January. We now face a rather significant amount of dilution from consultant shares. Due to the lack to transperancy I have to be a seller over the next few days along with those that I must apologize to. Good luck to all the longs and core here I really hope things improve!
Market Maker BTIG has the stock boxed in, has been controlling the price over the last week.
Thanks Guts, I look forward to making my full time job cycling!!
Agreed, just hard to see my portfolio down 40% I own 1.2 m of the stock and would love to see this company provide us with positive news, especially knowing how many shares have unlocked and need to be absorbed. JMHO and hopes.
Thanks BSAV, I did view those links the first time you posted them, not on this board, and that is why I really feel that they still hold a sizeable investment in SCRC. This is good and bad for me because as they invest for a living they will certainly cover their due deligence. The bad part is that they considered SCRC a risky investment, by what I read on there site, that they got a significantly lower share price. So there are only a few others that could be selling at such a critical time and that is my point.
I am not sure that Ironridge is our seller here, if you visit their website the "about us page" and investment strategy paints an entirely different picture. Not that they could be misleading but for business purposes that would be limiting.
Ironridge Global Partners, LLC is a long-only institutional investor that assists public companies in financing operations and expansion. Ironridge Global seeks to unlock the full potential of cash-constrained businesses by supplying innovative financing solutions and flexible capital. The firm’s core objective is to propel the development of high growth companies in building more sustainable enterprises.
Ironridge Global brings traditional private equity financial sophistication to small cap public companies. The firm does not desire to influence or control management, will not restrict use of proceeds and requires no restrictive covenants. We will never take an affiliate or control position in companies. Ironridge Global exclusively places its trust in current management with strong vision for accelerated growth and increased shareholder value.
"Ironridge Global takes a tailored approach to understanding smaller companies and their unique financial situation, needs and goals. The firm has unbridled flexibility to create innovative and mutually beneficial financial structures, and develop individual solutions appropriate to current company and market conditions.
The firm acts as a passive capital partner geared to provide the lowest available cost of capital. Ironridge Global has developed processes enabling the firm to quickly structure flexible financial solutions based upon each company’s unique situation, perform expedited and streamlined due diligence, make decisions and close transactions quickly and efficiently. Ironridge Global is not a hedge fund, does not request anti-dilution protection or require any restrictive covenants."
obtained from: http://www.ironridgeglobal.com/life-program
Excellent post CHP, thanks.
P.S. At least 80% of the shareholders here are retail investors and not the paid promoters/free shares.
For me I have invested in this company because of its potential and not of the current circumstances. I think by now each investor on IHUB knows that this stock has the most convertibles (in number) than most stock. Many other OTC's have fare larger convertibles in just one deal. The anger from some of the share or non-share holders is understandable as well, no one wants paid promoters being given stock in their company, even though almost all penny stock companies do this, but usually it is disguised in the promoters disclosures and share holders find out a lot later. I prefer to look at this as a cost to keeping the lights on and the company having the potential to make this business work. The alternative would have been to close the doors. I also respect that the CEO will answer questions and does disclose the details pertaining to the buisness and the stock. This being said, whether it is the truth or not only time will tell. I have been in too many stocks that have many of the same hall marks, some bad others great.
As for the shares coming to market, let them come. Even if the share price falls to .05 or less, it will only be temporary, in my opinion. I do not feel that we will have to wait long to see how this will play out because the CEO and the core have made January a very key month. Thanks for everyones great DD here and I wish you all the best of luck!
The above is just my humble opinion.
Got some nice fills this a.m. but had to chase all afternoon from .105 and couldn't get them to fill the EOD at .13. Oh well tomorrow is another day.
That is not proof of the company's worth. If you have proof the company was directly involved this would be something the SEC would like to know as well. JMHO
I always have to wonder why so many posters suddenly know that a stock is a "dump". Most of the posts have absolutley no merit or proof. I can't blame most of the posters on here for being excited about an investment that they own and at times post irrational exuberance. The ones that post "death spiral" and allude to the company being a shell offer no proof. The company in the SEC filings must post factual information and many here interpret that information as they see fit. The ones that post what a wonderful day trade this is must have missed, PHOT, OLIE where millions have been made, check out the market cap on those wonders. SCRC has often stated revenues, I doubt Bob would want to spend time in jail for fraud? As for the day trades the movements of even 100,000 shares would have provided $1,000 minus taxes and trade costs, seems hardly worth the stress or possible loss on a stock one believes to be a scam. I do know the CEO added 100,000 shares to his total recently at .145, interesting for a company on its last legs. Oh yeah the companies named above have astronomically high AS, this company has 125 m AS, really nothing for a penny stock. I think that CHP had it right it justs depends on your stomach for risk/reward and digging for information. Thanks for those that provided shares today and the best of luck to all, wether pro or con.
This is just my opinion.
Here is the link for any other investor that would like to review:
http://google.brand.edgar-online.com/EFX_dll/EDGARpro.dll?FetchFilingHtmlSection1? SectionID=7988790-92911-132276&SessionID=SLguFWfPE6GPHa2
Great, then you also know that the approval process was started in 2010 and it takes 2 - 3 years for review and approval in the U.S. I believe you read that in the companys posting with the largest limiting factor being funds.
Here is how the FDA approves OTC meds:
OTC drugs are drugs that have been found to be safe and appropriate for use without the supervision of a health care professional such as a physician, and they can be purchased by consumers without a prescription. These drugs are sometimes approved under applications like new prescription drugs, but more often they are legally marketed without an application by following a regulation called an OTC drug monograph.
An OTC drug monograph tells what kind of ingredients may be used to treat certain diseases or conditions without a prescription, and the appropriate dose and instructions for use. OTC products that meet a monograph’s requirements may be marketed without FDA review. OTC products that do not fit under an existing monograph must be approved under an application like the applications for prescription products.
Source FDA basics. FDA.gov
With all the talk about dilution and the launch of Rapidmeds, I found this article posted on the CNBC site Monday June 24th 2013 to be of great interest:
"Forbes released a statement, which read, "The key to RapiMed®'s sales and distribution success in China is having access to proven distribution channels for pharmaceutical and OTC products. We have intro access to a proven network of hospitals, drug stores and pharmacies."
The Forbes statement further read, "Once ScripsAmerica has opened a distribution network, either through license or joint venture participation funded by Chinese investment bankers, it will open up a tremendous opportunity to expand beyond China into the rapidly growing Asian market. With China's worldwide push to grow its marketplace and fund expansion into developing countries through distribution and acquisition, a ScripsAmerica – China joint venture could be an enormous benefit to existing ScripsAmerica shareholders."
The spokesperson for Forbes said, "China is aggressively making expansion capital available through direct investment and loans into the targeted expansion zones of Malaysia, the Philippines, Vietnam, Cambodia and Laos. Add to this the huge pharmaceutical markets next door including South Korea, Taiwan and Japan, and such a joint venture could easily have a pronounced effect on the Company's existing gross sales, enabling it to become its own publicly traded entity."
Forbes said, "The Chinese marketplace should provide fast acceptance of RapiMed®, which offers our distribution partners Western know-how, branding and joint marketing and distribution efforts that mutually benefit both parties. We are already looking into RediMed® adaptation market opportunities that include additional children's products and have been asked to look at the pharmaceutical and OTC products aimed at the fast-growing elderly market. Additionally, an exciting bonus opportunity exists in Japan, addressing its major multi-level marketing companies that are constantly looking for cutting edge new products or ways to improve current products."
"It is important to remember that we are positioning ScripsAmerica's growth in China to be a part of the country's 'Go Global' strategy, whereby the government is providing billions of dollars in loans to foreign countries to acquire Chinese manufactured goods through banks and investing partners. It is not a stretch of the imagination to envision the manufacture and export of Scrips-China RapiMed® products into this exploding global marketplace."
The official "Memorandum of Understanding" will be submitted to ScripsAmerica on June 25th to be signed by both parties the week of July 5th. The Company expects the signing of the "Definitive Agreement" to occur before the end of September, which will include initial production and shipping schedules."
Great trading day today, only need another 200K to finish obtaining my position. JMHO, GLTA